Real-time PCR, Digital PCR & End-point PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology (Quantitative, Digital, Endpoint), By Product (Consumables & Reagents, Instruments, Software & Services), By Application (Clinical, Research), By Region, By Competition Forecast & Opportunities, 2018-2028F
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationReal-time PCR, Digital PCR & End-point PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology (Quantitative, Digital, Endpoint), By Product (Consumables & Reagents, Instruments, Software & Services), By Application (Clinical, Research), By Region, By Competition Forecast & Opportunities, 2018-2028F
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 8.01 billion |
| CAGR (2023-2028) | 6.03% |
| Fastest Growing Segment | Clinical |
| Largest Market | North America |
Market Overview
Global Real-time PCR, Digital PCR & End-point PCR Market has valued at
Key Market Drivers
Rising Incidence Of Chronic Diseases, Infectious Diseases, And Genetic Disorders
Increasing Demand For Rapid Diagnostic Tests And Growing Adoption Of Qpcr & Dpcr
implementation of MIQE (Minimum Information for Publication of Quantitative Real-Time PCR Experiments)
Technological advancements in PCR (Polymerase Chain Reaction)
Key Market Challenges
High Device Costs Associated With Real Time Pcr
Stringent Regulatory Policies
Key Market Trends
Genomics research
Point-of-care testing (POCT)
Segmental Insights
Product Insights
Technology Insights
Regional Insights
Recent Developments
- In July 2023, QIAGEN launched CGTViral Vector Lysis kit for the biopharma industry, expanding its range ofdigital PCR kits and services. This is aimed at facilitating the development ofcell and gene therapies in the biopharma sector.
- In October 2022, StandardBioTools (formerly known as Standard BioTools) launched the X9 Real-time PCRSystem, a productive and high-capacity genomics platform. With more than 9,000unique nanoliter-volume reactions in a single run, X9 offers high data output,ensuring efficient, thorough sample profiling with little operator involvement.
- In September 2021, Thermo FisherScientific launched the Applied Biosystems QuantStudio Absolute Q digital PCRsystem, thus expanding its genetic analysis capabilities. It is the first fullyintegrated digital PCR (dPCR) system that is designed to provide consistent andhighly accurate results within 90 minutes.
- In June 2021, Bio-Rad introducedits PREvalence ddPCR SARS-CoV-2 wastewater quantification kit for testingCOVID-19 wastewater at a competitive price.
Key Market Players
- AbbottLaboratories Inc
- Bio-RadLaboratories Inc.
- ThermoFisher Scientific, Inc.
- BIOMÉRIEUXSA
- FluidigmCorporation
- F.Hoffmann-La Roche Ltd
- GEHealthcare
- AgilentTechnologies, Inc.
- QiagenNV
- MicrosynthAg
| By Technology | By Product | By Application | By Region |
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy